Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 927679-54-7 | MDL No. : | MFCD12198680 |
Formula : | C11H17NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GYEQQDCMLKKYGG-DHBOJHSNSA-N |
M.W : | 227.26 | Pubchem ID : | 39871576 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.5% | Stage #1: With sodium hydroxide In ethanol at 0 - 20℃; for 3 h; Stage #2: With hydrogenchloride In water |
The tert-butyl 6-ethoxycarbonyl-3-azabicyclo[3.1.0]hexane-3-carboxylate exo-isomer (613 mg, 2.40 mmol) prepared in Example 2 was dissolved in 6 mL of ethanol and 2N NaOH (2.40 mL, 4.80 mmol) was added dropwise at 0° C. After stirring at room temperature for 3 hours, the completion of the reaction was confirmed by TLC (hexane:ethyl acetate=6:1). After the reaction was completed, the reaction mixture was concentrated under reduced pressure and then extracted by adding methylene chloride and water. After removing the organic layer containing byproducts, the aqueous layer was acidified with 1N HCl and extracted with methylene chloride. The organic layer was dried with anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain 527 mg (96.5percent) of the target compound. 1H NMR (300 MHz, CDCl3) δ 3.74 (d, J=11.1 Hz, 1H), 3.66 (d, J=11.3 Hz, 1H), 3.53-3.45 (m, 2H), 2.17 (br, 2H), 1.55-1.53 (m, 1H), 1.48 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | INTERMEDIATE 13fert-butyl (lj¾, 5ff, 6r)-6-( 1,3 i14-oxadiazol-2-yl)-3-azabicyclo [3.1.0] hexane-3-carboxylate (i-13)Step A: /gr/-butyl ( IR. 5S, 6/)-6-(hydrazinocarbonyl)-3-azabicyclo [3.1.0] hexane-3-carboxylate; HBetaomicronomicronNu^ "OmicronNuEtaNu¾To a solution of 4.50 g (19.8 mmol) (IR, 5S, 6r)-3-(tert-butoxycarbonyl)-3- azabicyclo [3.1.0] hexane-6-carboxylic acid in 50 ml anhydrous tetrahydrofuran at -10C was added 3.04 ml (21.8 mmol) triethylamine followed by 2.08 ml (21.8 mmol) ethyl chloroformate slowly. The reaction was stirred between -20C to -10C for 20 min. The solid was filtered off and rinsed with tetrahydrofuran. The tetrahydrofuran filtrate was added into 1.04 ml (33.4 mmol) hydrazine hydrate in 50 ml anhydrous methanol at 0C. The reaction was stirred at ambient temperature for 2 h. The crude product was concentrated and purified by using a Biotage Horizon system (0-10% ethyl acetate/methanol with 10% ammonia) to give 3.0 g (75%) of the title compound as white solid. 1H NMR (CDC13): delta 3.67 (d, J = 1 1.2 Hz, 1H), delta 3.65 (d, J - 10.8 Hz, 1H), delta 3.42 (d, J = 10.7 Hz, 2H), delta 2.09 (s, 2H), 6 1.43 (s, 9H)5 delta 1.31 (m,lH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 1h; | Example 47: Synthesis of (2S,5R)-2-(5-(3-az.abicyclof3.1.0]hexan-6-yl)-l,3A-oxadiazol-2- -7-oxo-l ,6-diaz.abicyclol 3.2.1 loctan-6-yl hydrogen sulfate (Compound 740) ESI-MS (Epsilon , m/z): 372.3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.5% | The tert-butyl 6-ethoxycarbonyl-3-azabicyclo[3.1.0]hexane-3-carboxylate exo-isomer (613 mg, 2.40 mmol) prepared in Example 2 was dissolved in 6 mL of ethanol and 2N NaOH (2.40 mL, 4.80 mmol) was added dropwise at 0 C. After stirring at room temperature for 3 hours, the completion of the reaction was confirmed by TLC (hexane:ethyl acetate=6:1). After the reaction was completed, the reaction mixture was concentrated under reduced pressure and then extracted by adding methylene chloride and water. After removing the organic layer containing byproducts, the aqueous layer was acidified with 1N HCl and extracted with methylene chloride. The organic layer was dried with anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain 527 mg (96.5%) of the target compound. 1H NMR (300 MHz, CDCl3) delta 3.74 (d, J=11.1 Hz, 1H), 3.66 (d, J=11.3 Hz, 1H), 3.53-3.45 (m, 2H), 2.17 (br, 2H), 1.55-1.53 (m, 1H), 1.48 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With ammonia; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In methanol; dichloromethane; at 0 - 20℃; for 4h; | Add (1R, 5S) -6-carbamoyl-3-azabicyclo [3.1.0] hexane-3-carboxylic acid(21A) (refer to Bioorganic & Medical Chemistry, 24 (21), 5028-5035; 2016) (0.50 g, 2.2 mmol) was dissolved in dichloromethane (10 ml), and EDCI (0.51 g, 2.66 mmol) was slowly added dropwise in order. , 0.50 ml of HOBT (0.36 g, 2.7 mmol) and diisopropylethylamine, reduce the temperature to 0 C, add 0.5 ml of a 7 mol / L ammonia methanol solution, and react at room temperature for 4 hours. Dichloromethane (30 ml) and water (10 ml) were added to the reaction solution, and the mixture was extracted and separated. The organic phase was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure, and separated by column chromatography (dichloromethane / methanol (v / v ) = 15/1), (1R, 5S) -6-carbamoyl-3-azabicyclo [3.1.0] hexane-3-carboxylic acid tert-butyl ester (21B) (0.50 g, yield 100%). |
78% | With ammonia; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In methanol; dichloromethane; at 0 - 20℃; | To a 100-mL round-bottom flask was added (l S,5R)-3-tert- butoxycarbonyl-3- azabicyclo [3.1.0]hexane-6-carboxylic acid (2.00 g, 8.80 mmol, 1 equiv), l-(3- dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.04 g, 10.6 mmol, 1.2 equiv), and 1-hydroxybenzotriazole (1.43 g, 10.6 mmol, 1.2 equiv) in DCM (24 mL). N,N- diisopropylethylamine (1.86 mL, 10.6 mmol, 1.2 equiv) was added dropwise and then the reaction was cooled to 0C. Then a 2.0 M solution of NEb in MeOH (19.9 mL, 39.8 mmol) was added dropwise to the solution and the reaction was stirred for 4 hours at room temperature. After 4 hours, the reaction was diluted with DCM, washed with brine, extracted 3 times with DCM, dried over a2S04, and concentrated under vacuum. The crude product was purified by column chromatography (10% MeOH in DCM) to afford tert-butyl (l S,5R)-6-carbamoyl-3- azabicyclo[3.1.0]hexane-3-carboxylate as a white crystalline solid (1.561 g, 78% yield). |
70.6% | With 1,2,3-Benzotriazole; ammonia; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In methanol; dichloromethane; at 0 - 20℃; for 4h; | The <strong>[927679-54-7]3-(tert-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid</strong> (252 mg, 1.11 mmol) prepared in Example 3, benzotriazole (180 mg, 1.33 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (255 mg, 1.33 mmol) were dissolved in 3.0 mL of methylene chloride and diisopropylethylamine (232 muL, 1.33 mmol) was added dropwise. After adding 2 M ammonia solution (2.49 mL, 4.98 mmol) dissolved in methanol dropwise at 0 C., the mixture was stirred at room temperature for 4 hours. The completion of the reaction was confirmed by TLC(CH2Cl2:MeOH=15:1). After the reaction was completed, the reaction mixture was diluted with methylene chloride and washed with saturated sodium chloride. The organic layer was dried with anhydrous magnesium sulfate, filtered, concentrated under reduced pressure and separated by column chromatography (CH2Cl2:MeOH=15:1) to obtain 177 mg (70.6%) of the target compound. 1H NMR (300 MHz, CDCl3) delta 5.59 (br, 1H), 5.30 (br, 1H), 3.72 (d, J=10.3 Hz, 1H), 3.63 (d, J=11.2 Hz, 1H), 3.49-3.45 (m, 2H), 2.12 (br, 2H), 1.48 (s, 9H), 1.32 (t, J=2.88 Hz, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With borane-THF; In tetrahydrofuran; at 20℃; for 99h; | To a solution of (lR,5S,6r)-<strong>[927679-54-7]3-(tert-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid</strong> (250.8 mg, 1.104 mmol) in tetrahydrofuran (5.0 mL, 62 mmol) was dropwise added borane- tetrahydrofuran complex (1.0 mol/L) in tetrahydrofuran (2.20 mL, 2.2 mmol). The reaction mixture was stirred at room temperature for 20 hours. To the reaction was added borane- tetrahydrofuran complex (1.0 mol/L) in tetrahydrofuran (2.20 mL, 2.2 mmol). After an additional 7 hours borane-tetrahydrofuran complex (1.0 mol/L) in tetrahydrofuran (3.0 mL, 3.0 mmol) was added and the reaction mixture stirred at room temperature for 3 days. The reaction mixture was diluted with dichloromethane, washed with water and brine, dried over magnesium sulfate, filtered, and evaporated in vacuo to provide a quantitative yield of the title compound which was carried forward without purification. LCMS (ESI): [M+H-tBu]+ = 158.4; lH NMR (400 MHz, DMSO-d6): delta 4.45 (t, J = 5.5 Hz, 1H), 3.47 - 3.34 (m, 3H), 3.29 - 3.25 (m, 2H), 3.26 - 3.18 (m, 2H), 1.41 - 1.38 (m, 2H), 1.37 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92.1% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; for 3h; | The <strong>[927679-54-7]3-(tert-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid</strong> (185 mg, 0.812 mmol) prepared in Example 3, hydroxybenzotriazole (132 mg, 0.975 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (187 mg, 0.975 mmol) were dissolved in 3.0 mL of methylene chloride and the (5-isobutyl-3-aminomethyl-1-phenyl)pyrazole (205 mg, 0.894 mmol) prepared in Example 9 was added dropwise. After stirring for 3 hours, the completion of the reaction was confirmed by TLC (hexane:ethyl acetate=1:2). After the reaction was completed, the mixture was extracted with methylene chloride after adding water and saturated sodium bicarbonate. The organic layer was dried with anhydrous sodium sulfate, filtered, concentrated under reduced pressure and separated by column chromatography (hexane:ethyl acetate=1:2) to obtain 328 mg (92.1%) of the target compound. 1H NMR (300 MHz, CDCl3) delta 7.54-7.40 (m, 5H), 6.26 (br, 1H), 6.17 (s, 1H), 4.53 (d, J=5.01 Hz, 2H), 3.69 (d, J=11.9 Hz, 1H), 3.60 (d, J=11.1 Hz, 1H), 3.47-3.43 (m, 2H), 2.53 (d, J=7.14 Hz, 2H), 2.12 (br, 2H), 1.90-1.81 (m, 1H), 1.47 (s, 9H), 1.29 (t, J=3.27 Hz, 1H), 0.90 (d, J=6.60 Hz, 6H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; for 2h; | HATU (326 mg, 0.858 mmol) is added to meso-(1 R,5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3.1 .0]hexane-6-carboxylic acid (150 mg, 0.660 mmol), example 8i (397mg, 30% content, 0.92 mmol) and DIPEA (345 p1, 1,98 mmol) in dry DMF (2 mL) and stirring is continued for 2h.Volatiles are evaporated under reduced pressure to furnish a residue that is diluted with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layers is separated, dried on a Phase separatorcartridge and evaporated under reduce pressure to give a residue purified by flashchromatography (eluent DCM 100% to DCMMeOHNH4OH 9550.5) to furnish thetitle compound (104 mg, 95%).1H NMR (300 MHz, DMSO-d6): 6 1 .39 (5, 9H), 1 .49 (t, J = 3.5 Hz, 1 H), 1 .54 (5, 6H),1 .69 (br t, 2H), 2.35 (5, 3H), 3.26- 3.30 (br d, J = 11 .7, Hz 2H), 3.45- 3.49 (br d, J =11 .7, Hz 2H), 7.08 (dd, J = 4.7, 7.5 Hz, 1 H), 7.39 (dd, J = 1 .5, 7.6 Hz, 1 H), 8.25 (dd, J= 1.6,5Hz, 1H), 8.35 (5, 1H) |
104 mg | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; for 2h; | Example 9a 10530] HATU (326 mg, 0.858 mmol) is added to meso-(1R, 5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3. 1 .0]hexane-6-carboxylic acid (150 mg, 0.660 mmol), example 8i (397 mg, 30% content, 0.92 mmol) and DIPEA (345 pi, 1.98 mmol) in dry DMF (2 mE) and stirring is continued for 2 h. Volatiles are evaporated under reduced pressure to thmish a residue that is diluted with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layers is separated, dried on a Phase separator cartridge and evaporated under reduce pressure to give a residue purified by flash chroma76 tography (eluent DCM 100% to DCMMeOHNH4OH 9550.5) to thrnish the title compound (104 mg, 95%).10531] ?H NMR (300 MHz, DMSO-d5): oe 1.39 (s, 9H),1.49 (t, J=3.5 Hz, 1H), 1.54 (s, 6H), 1.69 (brt, 2H), 2.35 (s,3H), 3.26-3.30 (br d, J=1 1.7, Hz 2H), 3.45-3.49 (br d, J=1 1.7,Hz 2H), 7.08 (dd, J=4.7, 7.5 Hz, 1H), 7.39 (dd, J=1 .5, 7.6 Hz,1H), 8.25 (dd, J=1.6, 5 Hz, 1H), 8.35 (s, 1H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
56% | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; at 20℃; for 2h; | HATU (103 mg, 0.272 mmol) is added to meso-(1R,55,6r)-3-(tert-butoxycarbonyl)-3- azabicyclo[3.1 .0]hexane-6-carboxylic acid (48 mg, 0.21 mmol), example 13a (40 mg, 0.21 mmol) and DIPEA (109 p1, 0.627 mmol) in dry DMF (1 mL) and stirring is continued for 2h at rt. Volatiles are evaporated under reduced pressure to furnish a residue that is diluted with ethyl acetate and washed with saturated NaHCO3 and brine.The organic layer is separated, dried on a Phase separator cartridge and evaporated under reduce pressure to give a residue purified by flash chromatography (eluent 30-50% EtOAc/cyclohexane) to furnish the title compound (48 mg, 56%).HPLC-MS (Method 8): R = 3.73 mmMS (APCI): mlz = 401(M+H)+ |
56% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 2h; | Example 14a 10589] HATU (103 mg, 0.272 mmol) is added to meso-(1R, 55,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3. 1 .0]hexane-6-carboxylic acid (48 mg, 0.21 mmol), example 13a (40 mg,0.21 mmol) and DIPEA (109 pi, 0.627 mmol) in dry DMF (1 mE) and stirring is continued for 2 h at rt. Volatiles are evaporated under reduced pressure to furnish a residue that is diluted with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layer is separated, dried on a Phase separator cartridge and evaporated under reduce pressure to give a residue purified by flash chromatography (eluent 30-50% EtOAc/cyclohexane) to furnish the title compound (48 mg, 56%).10590] HPEC-MS (Method 8): R=3.73 mm 10591] MS (APCI): m/z=401 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; for 2h; | HATU (184 mg, 0.484 mmol) is added to meso-(1R,5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3.1 .0]hexane-6-carboxylic acid (100 mg, 0.440 mmol), example 18a (102mg, 0.440 mmol) and DIPEA (228 p1, 1 .32 mmol) in dry DMF (6 mL) and stirring is continued for 2h.Volatiles are evaporated under reduced pressure and the crude is taken up with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layers is separated, dried on a Phase separator cartridge and evaporatedunder reduce pressure to give a residue that is purified by flash chromatography(eluent 0-70% EtOAc/cyclohexane) to furnish the title compound (142 mg, 73%).U PLC-MS (Method 2): R = 1 .24 mmMS (ESI pos): mlz = 442 (M+H)+ |
73% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; for 2h; | Example 19a 10620] HATU (184 mg, 0.484 mmol) is added to meso-(1R, 55,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3 .1 .0]hexane-6-carboxylic acid (100 mg, 0.440 mmol), example 18a (102 mg, 0.440 mmol) and DIPEA (228 jii, 1.32 mmol) in dry DMF (6 mE) and stirring is continued for 2 h. Volatiles are evaporated under reduced pressure and the crude is taken up with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layers is separated, dried on a Phase separator cartridge and evaporated under reduce pressure to give a residue that is purified by flash chromatography (eluent 0-70% EtOAc/cyclohexane) to furnish the title compound (142 mg, 73%).10621] UPEC-MS (Method 2): R=1 .24 mm10622] MS (ESI pos): mlz=442 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; | HATU (95 mg, 0.251 mmol) is added to meso-(1 R,55,6r)-3-(tert-butoxycarbonyl)-3- azabicyclo[3.1 .0]hexane-6-carboxylic acid (52 mg, 0,228 mmol, commercially available from ABCR or WuXi AppTec, 1H NMR (500 MHz, DMSO-d6): 6 1 .24 (t, J =3.2, 1 H), 1 .38 (5, 9H), 1 .97 (t, J = 2.5 Hz ,2H), 3.34 (d, 2H), 3.48 (d, J = 11 .0 Hz, 2H),12.21 (br, 1 H)), example 2a (45mg, 0.228 mmol) and DIPEA (118 p1, 0.684 mmol) inDMF (1 mL) and stirring is continued overnight. Volatiles are evaporated underreduced pressure to afford a residue that is purified by flash chromatography (eluent0-40% EtOAc/cyclohexane) to furnish the title compound (72 mg, 78%).HPLC-MS (Method 7): R = 7.37 mmMS (APCI): m/z = 407 (M+H) |
78% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; | Example 3a j0404] HATU (95 mg, 0.25 1 mmol) is added to meso-(1R, 5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3 .1 .0]hexane-6-carboxylic acid (52 mg, 0.228 mmol, commercially available from AI3CR or WuXi AppTec, ?H NMR (500 MHz, DMSO-d5): oe 1.24 (t, J=3.2, 1H), 1.38 (s, 9H), 1.97 (t, J=2.5 Hz, 2H), 3.34 (d, 2H), 3.48 (d, J=11.0 Hz, 2H), 12.21 (br, 1H)), example 2a (45 mg, 0.228 mmol) and DIPEA (118 jii,0.684 mmol) in DMF (1 mE) and stirring is continued overnight. Volatiles are evaporated under reduced pressure to afford a residue that is purified by flash chromatography (eluent 0-40% EtOAc/cyclohexane) to thmish the title compound (72 mg, 78%).j0405] HPEC-MS (Method 7): R=7.37 mmj0406] MS (APCI): m/z=407 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine; In N,N-dimethyl-formamide; for 3h; | TBTU (70 mg, 0.218 mmol) is added to meso-(1 R,5S,6r)-3-(tert-butoxycarbonyl)-3- azabicyclo[3.1 .0]hexane-6-carboxylic acid (45 mg, 0,198 mmol), example 2c (46 mg, 91% content, 0.218 mmol) and TEA (80 p1, 0.594 mmol) in dry DMF (1,5 mL) and stirring is continued for 3h. The reaction is diluted with water and washed with ethyl ether. The organic layer is washed with NaHCO3 satured solution and water, then isseparated, dried and evaporated under reduced pressure to furnish the title compound (85 mg, 86%) that is used as such.U PLC-MS (Method 1): Rt = 1 .46 mm MS (ESI pos): mlz = 403 (M+H)+ |
85 mg | With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine; In N,N-dimethyl-formamide; for 3h; | Example 3i j0409] TI3TU (70 mg, 0.2 18 mmol) is added to meso-(1R, 5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3 .1 .0]hexane-6-carboxylic acid (45 mg, 0.198 mmol), example 2c (46 mg, 91% content, 0.2 18 mmol) and TEA (80 tl, 0.594 mmol) in dry DMF (1.5 mE) and stirring is continued for 3 h. The reaction is diluted with water and washed with ethyl ether. The organic layer is washed with NaHCO3 satured solution and water, then is separated, dried and evaporated under reduced pressure to furnish the title compound (85 mg, 86%) that is used as such.10410] UPEC-MS (Method 1): R=1.46 mm10411] MS (ESI pos): mlz=403 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In tetrahydrofuran; at 20℃; for 72h; | Meso-(1 R,5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3.1 .O]hexane-6-carboxylic acid (215 mg, 0.946 mmol), TEA (600 pL, 4.300 mmol), HATU (360 mg, 0.946 mmol) are added in sequence to example 22a (182 mg, 0.817 mmol) dissolved in THE (10 mL).Stirring is continued for 72h at rt. The reaction is washed with HCI 1 N solution, then with NaOH 1 N solution and brine. The organic layer is dried, filtered and evaporated under reduced pressure to give a residue that is purified by flash chromatography (eluent EtOAc/cyclohexane 15:85) to furnish the title compound (255 mg, 81 %).U PLC-MS (Method 2): R = 0.94 mmMS (ESI pos): mlz = 385 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In tetrahydrofuran; at 20℃; | General procedure: Meso-(1 R,5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3.1 .O]hexane-6-carboxylic acid (215 mg, 0.946 mmol), TEA (600 pL, 4.300 mmol), HATU (360 mg, 0.946 mmol) are added in sequence to example 22a (182 mg, 0.817 mmol) dissolved in THE (10 mL).Stirring is continued for 72h at rt. The reaction is washed with HCI 1 N solution, then with NaOH 1 N solution and brine. The organic layer is dried, filtered and evaporated under reduced pressure to give a residue that is purified by flash chromatography (eluent EtOAc/cyclohexane 15:85) to furnish the title compound (255 mg, 81 %). Example 23b is prepared in analogy to example 23a from example 22b (41 mg, 90% content, 0.132 mmol) as starting material. After stirring the reaction overnight, volatiles are removed and the resulting residue is purified by flash chromatography (eluent 0-60% EtOAc/cyclohexane) to furnish the title compound (41 mg, 95% content, 69%).U PLC-MS (Method 2): R = 1 .20 mmMS (ESI pos): mlz = 453 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
25 mg | With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In dichloromethane; at 20℃; for 20h; | Meso-(1 R,55,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3.1 .0]hexane-6-carboxylic acid (66 mg, 0.290 mmol), TEA (167 pL, 1 .20 mmol), HATU (110 mg, 0.290 mmol) are added in sequence to example 22d (51 mg) dissolved in dry DCM (7 mL). Stirring iscontinued for 20h at rt. The reaction is washed first with water, then with NaOH 1 N solution and brine. The aqueous layer is diluted with brine again and extracted with a mixture of EtOAc/MeOH 9:1. The organic layer is dried, filtered and evaporated under reduced pressure to give a residue that is purified by flash chromatography (eluent EtOAc/MeOH 9:2) to furnish the title compound (25 mg)U PLC-MS (Method 2): R = 0.74 mmMS (ESI pos): m/z = 386 (M+H) |
25 mg | With triethylamine; HATU; In dichloromethane; at 20℃; for 20h; | Example 23d 10748] Meso-(1 R,5S,6r)-3-(tert-butoxycarbonyl)-3-azabi- cyclo[3.1.0]hexane-6-carboxylic acid (66 mg, 0.290 mmol), TEA (1674, 1.20 mmol), HATU (110mg, 0.290 mmol) are added in sequence to example 22d (51 mg) dissolved in dry DCM (7 mE). Stirring is continued for 20 hat rt. The reaction is washed first with water, then with NaOH iN solution and brine. The aqueous layer is diluted with brine again and extracted with a mixture of EtOAc/MeOH 9:1. The organic layer is dried, filtered and evaporated under reduced pressure to give a residue that is purified by flash chromatography (eluent EtOAc/MeOH 9:2) to furnish the title compound (25 mg)j0749] UPLC-MS (Method 2): R0.74 mm10750] MS (ESI pos): mIz386 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35 mg | With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In tetrahydrofuran; | Example 22e (30 mg, 0.12 mmol), meso-(1R,5S,6r)-3-(tert-butoxycarbonyl)-3- azabicyclo[3.1 .0]hexane-6-carboxylic acid (33 mg, 0.140 mmol), Et3N (53 pL, 0.38 mmol) and HATU (54 mg, 0.140 mmol) are suspended in dry THE (5 mL) and themixture stirred over a weekend. The solvent is removed, the residue red issolved in DCM, washed with 0.2M aqueous NaOH solution and brine. The organic layer is dried, filtered and evaporated under reduced pressure to give a residue that is purified by flash chromatography (eluent 0-100 % EtOAc in cyclohexane) to give the title compound (Yield 35 mg)U PLC-MS (Method 2): R = 1 .11 mmMS (ESI pos): mlz = 425 (Mi-H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
118 mg | With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In dichloromethane; for 1h; | HATU (205 mg, 0.540 mmol) is added to meso-(1 R,55,6r)-3-(tert-butoxycarbonyl)-3- azabicyclo[3.1 .0]hexane-6-carboxylic acid (123 mg, 0.540 mmol), example 28a (100 mg) and TEA (301 p1, 2.160 mmol) in dry DCM (1 mL) and stirring is continued for lh.The mixture is washed with 1 N NaOH and brine. The organic phase is separated, dried and evaporated under reduced pressure.The resulting residue is purified by flash chromatography (eluent 0-5% MeOH/EtOAc) to furnish the title compound (118 mg).UPLC-MS (Method 2): R = 0.90 mmMS (ESI pos): mlz = 386 (M+H)+ |
118 mg | With triethylamine; HATU; In dichloromethane; for 1h; | Example 29a 10846] HATU (205 mg, 0.540 mmol) is added to meso-(i R, 55,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3 .1 .0]hexane-6-carboxylic acid (123 mg, 0.540 mmol), example 28a (100 mg) and TEA (301 jii, 2.160 mmol) in dry DCM (1 mE) and stirring is continued for 1 h. The mixture is washed with iN NaOH and brine. The organic phase is separated, dried and evaporated under reduced pressure. The resulting residue is purified by flash chromatography (eluent 0-5% MeOH/ EtOAc) to thmish the title compound (118 mg).10847] UPEC-MS (Method 2): R=0.90 mm10848] MS (ESI pos): mlz=386 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In tetrahydrofuran; for 2h; | HATU (134 mg, 0.353 mmol) is added to meso-(1R,5S,6r)-3-(tert-butoxycarbonyl)-3- azabicyclo[3.1 .0]hexane-6-carboxylic acid (80 mg, 0.353 mmol), example 28b (56 mg, 0.294 mmol) and TEA (90 p1, 0.648 mmol) in dry THE (5 mL) and stirring iscontinued for 2h. Solvent is removed and the resulting residue is purified by flashchromatography (eluent 0-100% EtOAc/Cyclohexane)to furnish the title compound(107 mg, 91%).UPLC-MS (Method 2): R = 0.96 mmMS (ESI pos): mlz = 400 (M+H) |
91% | With triethylamine; HATU; In tetrahydrofuran; for 2h; | Example 29b 10850] HATU (134 mg, 0.353 mmol) is addedto meso-(1R,5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3 .1 .0]hexane-6-carboxylic acid (80 mg, 0.353 mmol), example 28b (56 mg,0.294 mmol) and TEA (90 jii, 0.648 mmol) in dry THF (5 mE)and stirring is continued for 2 h. Solvent is removed and theresulting residue is purified by flash chromatography (eluent0-100% EtOAc/Cyclohexane) to thrnish the title compound(107 mg, 91%).10851] UPEC-MS (Method 2): R=0.96 mm10852] MS (ESI pos): mlz=400 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; | HATU (295 mg, 0.775 mmol) is added to meso-(1 R,5S,6r)-3-(tert-butoxycarbonyl)-3- azabicyclo[3.1 .0]hexane-6-carboxylic acid (136 mg, 0.596 mmol), example 28d (150 mg, 80% content, 0.596 mmol) and DIPEA (312 p1, 1,79 mmol) in DMF (2 mL) andstirring is continued overnight. Volatiles are evaporated under reduced pressure to furnish a residue that is diluted with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layers is separated, dried on a Phase separator cartridge and evaporated under reduce pressure to give a residue purified by flash chromatography (eluent 0-50% EtOAc/cyclohexane) to furnish the title compound(150 mg,61%).UPLC-MS (Method 2): R = 1.17 mmMS (ESI pos): mlz = 411 (M+H)+ |
150 mg | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; | Example 29d 10855] HATU (295 mg, 0.775 mmol) is added to meso-(1R, 5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3. 1 .0]hexane-6-carboxylic acid (136 mg, 0.596 mmol), example 28d (150 mg, 80% content, 0.596 mmol) and DIPEA (312 jii, 1.79 mmol) in DMF (2 mE) and stirring is continued overnight.Volatiles are evaporated under reduced pressure to thrnish a residue that is diluted with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layers is separated,dried on a Phase separator cartridge and evaporated under reduce pressure to give a residue purified by flash chromatography (eluent 0-50% EtOAc/cyclohexane) to thrnish the title compound (150 mg, 6 1%).10856] UPEC-MS (Method 2): R=1.17 mm |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; for 2h; | HATU (184 mg, 0.484 mmol) is added to meso-(1R,5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3.1 .0]hexane-6-carboxylic acid (84 mg, 0.371 mmol), example 33a (77mg, 85% content, 0.371 mmol) and DIPEA (194 p1, 1.114 mmol) in dry DMF (1 mL)and stirring is continued for 2h.Volatiles are evaporated under reduced pressure andthe crude is taken up with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layers is separated, dried on a Phase separator cartridge and evaporated under reduce pressure to give a residue that is purified by flash chromatography (eluent 0-40% EtOAc/cyclohexane) to furnish the title compound (60mg, 98% content, 41%).HPLC-MS (Method 12): R = 3.43 mmMS (ESI pos): mlz = 408 (M+Na) |
41% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; for 2h; | Example 34a [0892] [0893] HATU (184 mg, 0.484 mmol) is added to meso-<strong>[927679-54-7](1R,5S,6r)-<strong>[927679-54-7]3-(tert-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid</strong></strong> (84 mg, 0.371 mmol), example 33a (77 mg, 85% content, 0.371 mmol) and DIPEA (194 mul, 1.114 mmol) in dry DMF (1 mL) and stirring is continued for 2 h. Volatiles are evaporated under reduced pressure and the crude is taken up with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layers is separated, dried on a Phase separator cartridge and evaporated under reduce pressure to give a residue that is purified by flash chromatography (eluent 0-40% EtOAc/cyclohexane) to furnish the title compound (60 mg, 98% content, 41%). [0894] HPLC-MS (Method 12): Rt=3.43 min [0895] MS (ESI pos): m/z=408 (M+Na)+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; for 2h; | HATU (378 mg, 1,26 mmol) is added to meso-(1 R,55,6r)-3-(tert-butoxycarbonyl)-3- azabicyclo[3.1 .0]hexane-6-carboxylic acid (220 mg, 0.966 mmol), example 33b (300 mg, 98% content, 0.966 mmol) and DIPEA (505 p1, 2.90 mmol) in dry DMF (2 mL) and stirring is continued for 2h.Volatiles are evaporated under reduced pressure and the crude is taken up with ethyl acetate and washed with saturated NaHCO3 and brine. The organic layers is separated, dried on a Phase separator cartridge and evaporated under reduce pressure to give a residue that is purified by flash chromatography (eluent 0-40% EtOAc/cyclohexane) to furnish the title compound(276 mg, 72%).HPLC-MS (Method 11): R = 2.97 mmMS (ESI pos): mlz = 400 (M-f-H) |
Tags: 927679-54-7 synthesis path| 927679-54-7 SDS| 927679-54-7 COA| 927679-54-7 purity| 927679-54-7 application| 927679-54-7 NMR| 927679-54-7 COA| 927679-54-7 structure
A1277518[ 1401464-07-0 ]
rel-(1R,5S,6s)-3-(tert-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid
Reason:
[ N/A ]
(1R,5S,6s)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid
Similarity: 1.00
[ 1119512-39-8 ]
3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid
Similarity: 1.00
[ 1251012-36-8 ]
cis-3-(tert-Butoxycarbonyl)-3-azabicyclo[4.1.0]heptane-6-carboxylic acid
Similarity: 0.98
[ 150543-61-6 ]
5-(tert-Butoxycarbonyl)-5-azaspiro[2.4]heptane-1-carboxylic acid
Similarity: 0.98
[ 1363382-36-8 ]
5-(tert-Butoxycarbonyl)-5-azaspiro[2.5]octane-1-carboxylic acid
Similarity: 0.98
[ N/A ]
(1R,5S,6s)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid
Similarity: 1.00
[ 1119512-39-8 ]
3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid
Similarity: 1.00
[ 1251012-36-8 ]
cis-3-(tert-Butoxycarbonyl)-3-azabicyclo[4.1.0]heptane-6-carboxylic acid
Similarity: 0.98
[ 150543-61-6 ]
5-(tert-Butoxycarbonyl)-5-azaspiro[2.4]heptane-1-carboxylic acid
Similarity: 0.98
[ 1363382-36-8 ]
5-(tert-Butoxycarbonyl)-5-azaspiro[2.5]octane-1-carboxylic acid
Similarity: 0.98
[ N/A ]
(1R,5S,6s)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid
Similarity: 1.00
[ 1119512-39-8 ]
3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid
Similarity: 1.00
[ 1309352-51-9 ]
3-(tert-Butoxycarbonyl)-3-azabicyclo[4.1.0]heptane-6-carboxylic acid
Similarity: 0.98
[ 1251012-36-8 ]
cis-3-(tert-Butoxycarbonyl)-3-azabicyclo[4.1.0]heptane-6-carboxylic acid
Similarity: 0.98
[ 1363381-55-8 ]
3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-1-carboxylic acid
Similarity: 0.97
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :